Displaying 1 - 8 of 8 for Alzheimer's Disease
  • ADNI3 (H-39481)
    • This study tests whether serial magnetic resonance imaging, positron emission tomography, other biological markers, and clinical and neuropsychological assessment can be used together to measure mild cognitive impairment and Alzheimer’s progression.
  • A4 Study (H-3391)
    • The A4 study is investigating a new drug (solanezumab) that may reduce the amount of a protein known as "amyloid" or "beta amyloid" that forms plaque in the brain.
  • Database for Future Alzheimer's Disease Prevention Trials (H-31444)
    • The purpose of this project is to establish a registry of people who maybe interested in participating in studies that test the effectiveness of treatments to delay the onset of memory and thinking problems associated with Alzheimer's disease and dementia.
  • Engage Study (H-37832)
    • The purpose of this study is to determine the effectiveness and safety of aducanumab compared with a placebo (inactive substance) in people with mild cognitive impairment or early Alzheimer’s disease.
  • Healthy Aging Control Study (H-12081)
    • The purpose of this control study is to gain a better understanding of memory functioning in normal elderly control subjects.
  • SNIFF Study (H-33453)
    • This study will evaluate the use of intranasal insulin on memory functioning in adults with mild stage AD or memory loss due to MCI over a 12 month period of time compared with placebo.
  • TARCC Study (H-22404)
    • The purpose of this study is to learn more about Alzheimer's disease by combining efforts of several institutions across the State of Texas.
  • TOMORROW Study (H-32830)
    • The purpose of the study is to see if it is possible to predict if a person will develop mild cognitive impairment due to Alzheimer’s disease based on his/her genes and to test a medicine called pioglitazone (AD-4833).